The clinical relevance of the p53 tumour suppressor gene*
- 1 June 1994
- journal article
- review article
- Published by Wiley in Cytopathology
- Vol. 5 (3) , 133-145
- https://doi.org/10.1111/j.1365-2303.1994.tb00409.x
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Diagnostic associations of p53 immunostaining in fine needle aspiration cytology of the breastCytopathology, 1994
- Immunohistochemical examination of tumor-suppressor gene p53 product and pyrimidine dimer in solar keratosisZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Published by Elsevier ,1992
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- p53, guardian of the genomeNature, 1992
- Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast CancerJapanese Journal of Cancer Research, 1991
- The p53 tumour suppressor geneNature, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.Proceedings of the National Academy of Sciences, 1989
- Chromosome error propagation and cancerTrends in Genetics, 1989